Mark Kendall is a Professor of Biomedical Engineering at the University of Queensland, with 20 years of experience in research and innovation in producing solutions to global health problems. He is the Founder of Vaxxas and is a World Economic Forum Tech Pioneer 2015. He is an author of ~200 refereed publications; inventor on >130 patents (of which more than 70 have been granted thus far); and works closely with industrial partners in the technology transfer from concept to commercialisation. In addition to inventing the Nanopatch – and driving it forward towards product – Mark also contributed to the biolistics technology while serving as a Lecturer at Oxford University.

The biolistics technology was spun out to PowerJect (sold to Chiron for $1 billion (in 2003)) and then, as PowderMed to Pfizer for $400 million (in 2006). He has received numerous awards in recognition of his innovation and translation, including: the 2016 CSL Young Florey Medal, a 2012 Rolex Laureate for pioneering efforts to expand knowledge and improve human life, and Young Engineer of Britain (2004). Mark and his work have featured in many media outlets, including: TEDGlobal, WIRED, ABC, BBC, NBC, National Geographic, New Scientist, Popular Science and Vanity Fair.